Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing

The RNA-guided clustered regularly interspaced short palindromic (CRISPR) in combination with a CRISPR-associated nuclease 9 (Cas9) nuclease system is a new rapid and precise technology for genome editing. In the present study, we applied the CRISPR/Cas9 system to target ABCB1 (also named MDR1) gene...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transl Res
Autors principals: Yang, Yang, Qiu, Jian-Ge, Li, Yong, Di, Jin-Ming, Zhang, Wen-Ji, Jiang, Qi-Wei, Zheng, Di-Wei, Chen, Yao, Wei, Meng-Ning, Huang, Jia-Rong, Wang, Kun, Shi, Zhi
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040697/
https://ncbi.nlm.nih.gov/pubmed/27725879
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars